Analysis of Bax and Bcl-2 expression at mRNA levels also showed significant attenuation of Bcl-2 and enhancement of Bax mRNA levels after treatment of JVM-13 cells with IBS and MBS (Figure 2d). This evidence concerns the gene BAX and irritable bowel syndrome.